It’s time for a reckoning. For too long, Big Pharma has been living off taxpayer-backed innovation while charging Americans sky-high prices that would make a gold refinery blush. These so-called “innovators” rake in billions, inflate costs for life-saving drugs, and line beltway lobbyists’ pockets — all while families choose between medicine and rent.
Consider this: new drugs developed with taxpayer-funded NIH research now hit the market at an average launch price of $111,000, climbing as high as $1.9 million per course — an outrageous double charge on taxpayers.
Meanwhile, 58% of Americans view the industry negatively — understandably so, as brand-name drugs account for just 10% of prescriptions but gobble up 75% of total spending.
Read more at Newsmax© 2025 Newsmax. All rights reserved.
